Fresh analysis reveals that individuals who stop using new GLP-1 drugs like Mounjaro or Wegovy may regain shed pounds far faster than those who end traditional diet and exercise plans.
Findings released in a prominent medical journal points out that while overweight people can lose substantial amounts of their body weight while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing these medications need to be cognizant of the risk of rapid rebound weight gain when the therapy is stopped," cautioned lead investigator Dr. Susan Jebb.
Such speed of recovery implies a return to pre-treatment weight in about one and a half years.
Comparing Approaches
The study, which looked at 37 of trials involving thousands of participants, compared the effects of GLP-1 agonists with other pills.
Researchers emphasize that people who lose weight through diet and exercise typically see a slower creep back—around 100 grams monthly—once they finish.
The Reason for the Fast Rebound
Experts believe the mechanism of the injections explains the accelerated regain.
The injections copy a body's own chemical called GLP-1, which controls hunger.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and could reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making binge eating a significant risk."
A Lifelong Disease?
Health authorities recommend the jabs for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.
Professionals say that, given the high risk of weight regain, the treatment is often ongoing.
This opinion is supported by pharmaceutical companies, who note that the results "emphasize the long-term nature of obesity," similar to managing diseases like high blood pressure.
User Experiences
Users who have come off the medication report a intense return of appetite.
"It felt as if a trigger flipping and you're instantly ravenous," recalled an individual.
The struggle is worsened if individuals have not adopted sustainable dietary or behavioural modifications during treatment.
Significant Adoption
Figures indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with demand being substantial.
- Use is higher among women compared to men.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
Finally, clinicians caution that while the jabs are powerful agents for shedding pounds, they are not a magic fix and lasting health benefits relies on integrated lifestyle management.